Aster CMI Hospital, Datar Cancer Genetics launch Comprehensive Cancer Screening program
A simple blood test to diagnose 30 types of cancer
Bengaluru(Press Release): To commemorate World Cancer Day 2022, Aster CMI Hospital in association with Datar Cancer Genetics, a leading cancer research company launched Comprehensive Cancer Screening Programme today. With an aim to help patients detect cancer at its early stage that can save lives and drastically reduce the cost of cancer treatment, the hospital is bringing in EasyCheck360 (multiple cancers), EasyCheck FemmeSafe (women’s) and EasyCheck Prostrate cancer screening tests. EasyCheck is a revolutionary, radiation-free, globally recognized simple blood test for early cancer detection. It is clinically validated by one of the world’s largest clinical trials registered with the WHO clinical Trial Registry brought to you by Datar Cancer Genetics.
EasyCheck360 is a simple blood test that can detect more than 30 cancers. It is intended to be performed annually as a screening test, in individuals without any symptoms suggestive of cancer and aged > 30 years. And it can help detect cancers early that originate in the Oral Cavity, Lung, Breast, Esophagus, Stomach, Liver, Pancreas, Gallbladder, Kidney, Ovary, Cervix, Prostate, Bladder and specified Sarcomas. EasyCheck-FemmeSafe for women can detect cancers early that originate in the Breasts, Ovaries, Endometrium and Cervix. FemmeSafe is the outcome of intensive research efforts of the last several years by internationally recognized scientists and doctors. EasyCheck prostrate is a blood test that can detect Prostate Cancer and it is intended to be performed annually as a screening test, in individuals with no symptoms.
The technique employed is a proprietary technology which is a pathbreaking innovation, designed to detect circulating tumour cells (CTC) and their clusters before they become symptomatic or clinically detectable. The tests analyse CTC in the peripheral blood of an individual, are intended to detect the presence of malignant cells and have been clinically proven to have 88.19% Sensitivity and 99% Specificity in detecting cancer.
Speaking on the launch of the Comprehensive Cancer Screening Programme and the need for early detection for cancer, Dr. Vijay Agarwal, Lead & Sr. Consultant - Medical Oncology & Haematology, Aster CMI Hospital said, “In India, every year 1.2 million cases of cancer are diagnosed which accounts for 7,60,000 deaths. Due to changes in lifestyle as well as other risk factors, these numbers are slated to increase in the future. When cancer care is delayed there is a lower chance of survival, greater problems associated with treatment and higher costs. Hence, early detection and providing timely treatment are important which can significantly improve survival rates. Early detection of cancer requires early diagnosis and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while this screening consists of testing healthy individuals to identify those having cancers before any symptoms appear. I am sure that with the launch of this Comprehensive Cancer Screening Programme, one can avail to undergo testing which can help diagnose various types of cancers at the earliest.”
Speaking on the launch of EasyCheck360®: Breakthrough in Early Cancer Detection Ms. Samara Mahindra, Director, New Cancer Initiatives, Datar Cancer Genetics said, “Cancer has become a chronic disease and one which can be treated successfully if detected early. The key to beating cancer is screening and early detection. Early detection will lead to a high chance of survival in most cases. EasyCheck360® is a breakthrough test and will go a long way in helping witness a cancer free India”
About Aster DM Healthcare
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our hospitals, clinics and pharmacies. We have over 19,800+ plus dedicated employees across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Allen, Raghuvanshi, Green power KKR to 29-run win over GT
Kolkata (PTI): Finn Allen blasted a 35-ball 93, while Angkrish Raghuvanshi hit an unbeaten 44-ball 82 as Kolkata Knight Riders kept their playoff hopes alive with a 29-run win over Gujarat Titans in the IPL match here on Saturday.
Sent in to bat, Allen went on a six-hitting spree, smashing 10 maximums and four boundaries to add 95 off 41 balls with Raghuvanshi (82).
Raghuvanshi then shared another 108 off 53 balls with Cameron Green (52 not out) to power KKR to a challenging 247 for 2.
In reply, GT could manage 218-4, riding on skipper Shubman Gill's 49-ball 85 and a 35-ball 57 from Jos Buttler. Opener Sai Sudarsan was retired hurt but returned to make a 28-ball 53 not out.
Sunil Narine (2/29) claimed two wickets and Saurabh Dubey snapped one for KKR.
For GT, Mohammed Siraj (1/50), Sai Kishore (1/38) were the wicket-takers.
Brief Score:
KKR: 247 for 2 in 20 overs (Finn Allen 93, Angkrish Raghuvanshi 82 not out, Camero Green 52 not out; Mohammed Siraj 1/50).
GT: 218 for 4 in 20 overs (Shubman Gill 85, Sunil Narine 2/29).
